# Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

> **NCT01507727** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Non-hypovolemic Non-acute Hyponatremia

## Interventions

- **DRUG:** Tolvaptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01507727
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2012-01-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507727, "Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01507727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*